Case Study High throughput macromolecular crystallography The Problem Macromolecular crystallography (MX) is a key asset in the development of new drugs via structure based drug discovery. This process is now widely used by the pharmaceutical industry to gain structural insights into drug targets and map interactions with ligands. However, isolating and optimising a new lead compound is a time consuming process which usually involves screenin

Join for free to read